Clinical Trial Update: Radiotherapy in Combination With Atezolizumab in Locally Advanced Borderline Resectable or Unresectable Cutaneous SCC [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating radiotherapy in combination with atezolizumab for locally advanced, borderline resectable, or unresectable cutaneous squamous cell carc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Squamous Cell Carcinoma

Drugs mentioned

• Tecentriq (atezolizumab)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Locally Advanced Skin Squamous Cell Carcinoma, Resectable Skin Squamous Cell Carcinoma | Phase 1 | Status: RECRUITING